Robert Flavell, MD, PhD: Clinical Trials

6 trials sponsored by Robert Flavell, MD, PhD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 active not recruiting, 1 suspended. 5 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Recruiting 3, Active not recruiting 1, Suspended 1
Early Phase 11Recruiting 1

Follow Robert Flavell, MD, PhD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
[89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor
Phase 1RecruitingRobert Flavell, MD, PhD402026-06-152026-10-01
PET [89Zr]DFO-starPEG in Solid Tumors
89-zr-dfo-star polyethylene glycol (StarPEG), Whole Body Positron Emission Tomography (PET), Specimen Collection - Solid Tumor, Solid Carcinoma
Phase 1RecruitingRobert Flavell, MD, PhD132025-06-022026-06-05
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
Hyperpolarized Bicarbonate (13C), Magnetic Resonance imaging - Prostate Cancer, Localized Prostate Carcinoma
Early Phase 1RecruitingRobert Flavell, MD, PhD102023-07-062026-10-13
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Zirconium Zr 89-DFO-YS5, Positron Emission Tomography / Computed Tomography (PET/CT), Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) - Multiple Myeloma, Plasma Cell Myeloma
Phase 1RecruitingRobert Flavell, MD, PhD202023-06-162026-09-16
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
89Zr-DFO-YS5, YS5 antibody, Positron Emission Tomography (PET)/Computerized tomography (CT) - Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Phase 1Active not recruitingRobert Flavell, MD, PhD302022-03-182026-03-17
Zr-89 Cimzia PET Imaging Rheumatoid Arthritis
89Zr-DFO-CZP - Rheumatoid Arthritis
Phase 1SuspendedRobert Flavell, MD, PhD102018-10-012026-05-04

Conditions studied

Prostatic Neoplasms (2)  ·  Arthritis, Rheumatoid (1)  ·  Multiple Myeloma (1)  ·  Nerve Sheath Neoplasms (1)  ·  Pyloric Stenosis, Hypertrophic (1)  ·  Urinary Bladder Neoplasms (1)

Interventions

Magnetic Resonance Spectroscopy (4)  ·  Fluorodeoxyglucose F18 (1)  ·  Specimen Handling (1)  ·  acetyl-glycyl-asparagyl-glutaminyl-glutamyl-glutaminyl-valyl-seryl-prolyl-leucyl-threonyl-leucyl-leucyl-lysyl-lysyl-tryptophyl-cysteinyl-Alexa Fluoro 680 C2C2-maleimide conjugate (1)

Countries

United States (6)

Top investigators

Robert Flavell, MD (1)

NIH funding

R01CA266666 (1), R01CA271606 (1)